Innovation Pharmaceuticals Inc (IPIX)

[biodoc]

I hope Leo focuses on the science while prudently managing Cellceutix's finances. Also, I hope Leo doesn't generate a reactive PR to market action that does not impact the long term value of Cellceutix. Perhaps the volatility is clouding your long term vision?

Brilacidin Phase 3 meetings, advancement of Kevetrin with p53/p21 data, B-OM (placebo control group!) trial initiation, and Prurisol Phase 2 trial initiation are relatively near-term events that may greatly improve Leo's negotiating position. Leo knows what he's doing.